Literature DB >> 26585450

Characterization of a Novel Collagen Scaffold for Corneal Tissue Engineering.

Jie Zhang1, Aran M G Sisley1, Alexander J Anderson2, Andrew J Taberner2, Charles N J McGhee1, Dipika V Patel1.   

Abstract

Globally millions are blind due to corneal disease, yet tissue for transplantation is a limited resource. This study characterizes the physical and biological properties of a novel collagen-based scaffold. Transparency, optical coherence tomography (OCT), and scanning electron microscopy (SEM) were used to analyze the structure of the scaffold, synthesized using rat tail collagen I. Water content was determined. The tensile strength was assessed using a micro-mechanical analyzer. In vitro biocompatibility was assessed by culturing the scaffold with epithelial or keratocyte spheres. The mean scaffold transmittance was 0.72 at 358 nm, 0.88 at 570 nm, and 0.92 at 900 nm. OCT imaging confirmed that the scaffold maintained a corneal shape, with a central thickness of 502 μm and a reflectivity profile comparable to that of a normal human cornea. SEM of the scaffold revealed multiple lamellae on cross section. The mean water content was 88.7% ± 0.7%. Ultimate tensile strength for the noncross-linked scaffold was 1.23 ± 0.27 MPa compared with 2.21 ± 0.70 MPa for the cross-linked scaffold (human corneal anterior stroma 1.53 ± 0.86 MPa) at a strain rate of 0.5%/s. Epithelial cells migrated over the scaffold to confluence. Keratocytes populated the scaffold and maintained a lamellar arrangement. The properties of this novel scaffold suggest that it has potential to be developed into a corneal tissue substitute for human transplantation.

Entities:  

Year:  2015        PMID: 26585450     DOI: 10.1089/ten.TEC.2015.0304

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  8 in total

1.  Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation.

Authors:  Susi Burgalassi; Erica Zucchetti; Leonardo Ling; Patrizia Chetoni; Silvia Tampucci; Daniela Monti
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

2.  Human Bone Derived Collagen for the Development of an Artificial Corneal Endothelial Graft. In Vivo Results in a Rabbit Model.

Authors:  Natalia Vázquez; Manuel Chacón; Carlos A Rodríguez-Barrientos; Jesús Merayo-Lloves; Miguel Naveiras; Begoña Baamonde; Jose F Alfonso; Iriana Zambrano-Andazol; Ana C Riestra; Álvaro Meana
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

3.  Fabrication of transparent hemispherical 3D nanofibrous scaffolds with radially aligned patterns via a novel electrospinning method.

Authors:  Jeong In Kim; Ju Yeon Kim; Chan Hee Park
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

4.  Characterization of cornea-specific bioink: high transparency, improved in vivo safety.

Authors:  Hyeonji Kim; Moon-Nyeo Park; Jisoo Kim; Jinah Jang; Hong-Kyun Kim; Dong-Woo Cho
Journal:  J Tissue Eng       Date:  2019-01-25       Impact factor: 7.813

Review 5.  Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits.

Authors:  Martine Tarsitano; Maria Chiara Cristiano; Massimo Fresta; Donatella Paolino; Concetta Rafaniello
Journal:  Gels       Date:  2022-07-10

6.  Corneal stromal stem cells restore transparency after N2 injury in mice.

Authors:  Djida Ghoubay; Marie Borderie; Kate Grieve; Raphaël Martos; Romain Bocheux; Thu-Mai Nguyen; Patrice Callard; Alain Chédotal; Vincent M Borderie
Journal:  Stem Cells Transl Med       Date:  2020-05-07       Impact factor: 6.940

Review 7.  Bioengineering Approaches for Corneal Regenerative Medicine.

Authors:  S Sharareh Mahdavi; Mohammad J Abdekhodaie; Shohreh Mashayekhan; Alireza Baradaran-Rafii; Ali R Djalilian
Journal:  Tissue Eng Regen Med       Date:  2020-07-21       Impact factor: 4.169

Review 8.  Mechanobiology of the corneal epithelium.

Authors:  Sophia Masterton; Mark Ahearne
Journal:  Exp Eye Res       Date:  2018-08-04       Impact factor: 3.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.